This edition of Pharmacy Pearls reviews the available epinephrine injector options for the treatment of anaphylaxis. There are several devices available (both brand and generic), and the cost to patients…
One of the 2019 AHP Pharmacy Team targets is to limit the use of Nasonex for allergic rhinitis given the availability of equally effective and far less expensive OTC products,…
135 Corporate Woods, Suite 320
Rochester, New York 14623-1466
Phone: (585) 758-7823
Fax: (585) 424-1268
© Copyright - Accountable Health Partners - 2024
Website by: 
This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.
| ABI Value | Interpretation | Recommendation |
|---|---|---|
| Greater than 1.4 | Calcification/vessel hardening | Refer to vascular specialist |
| 1.0 - 1.4 | Normal | None |
| 0.9 - 1.0 | Acceptable | None |
| 0.8 - 0.9 | Some arterial disease | Treat risk factor |
| 0.5 - 0.8 | Moderate arterial disease | Refer to vascular specialist |
| Less than 0.5 | Severe arterial disease | Refer to vascular specialist |
